216 related articles for article (PubMed ID: 11909557)
1. Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema.
Frishman WH
Am J Cardiol; 2002 Mar; 89(6A):18D-25D. PubMed ID: 11909557
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 inhibition and renal physiology.
Harris RC
Am J Cardiol; 2002 Mar; 89(6A):10D-17D. PubMed ID: 11909556
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
Wolfe F; Zhao S; Pettitt D
J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
[TBL] [Abstract][Full Text] [Related]
5. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of cyclooxygyenase-2-selective inhibitors.
Brater DC
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S15-20; discussion S21-3. PubMed ID: 11992745
[TBL] [Abstract][Full Text] [Related]
8. An evidence-based evaluation of the gastrointestinal safety of coxibs.
Bombardier C
Am J Cardiol; 2002 Mar; 89(6A):3D-9D. PubMed ID: 11909555
[TBL] [Abstract][Full Text] [Related]
9. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors.
Cheng HF; Harris RC
Curr Pharm Des; 2005; 11(14):1795-804. PubMed ID: 15892676
[TBL] [Abstract][Full Text] [Related]
10. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
Galli G; Panzetta G
G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
[TBL] [Abstract][Full Text] [Related]
11. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclooxygenase-2 inhibitors on blood pressure.
Johnson DL; Hisel TM; Phillips BB
Ann Pharmacother; 2003 Mar; 37(3):442-6. PubMed ID: 12639178
[TBL] [Abstract][Full Text] [Related]
13. Initiation of antihypertensive therapy among new users of cyclooxygenase-2-selective and nonselective NSAIDs.
Langman MJ; Eichler HG; Mavros P; Watson DJ; Kong SX
Int J Clin Pharmacol Ther; 2004 May; 42(5):260-6. PubMed ID: 15176648
[TBL] [Abstract][Full Text] [Related]
14. The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents.
Armstrong EP; Malone DC
Clin Ther; 2003 Jan; 25(1):1-18. PubMed ID: 12637109
[TBL] [Abstract][Full Text] [Related]
15. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.
Noroian G; Clive D
Drug Saf; 2002; 25(3):165-72. PubMed ID: 11945113
[TBL] [Abstract][Full Text] [Related]
16. [Clinical application of cyclooxygenase-2 inhibitors].
Dzielska-Olczak M; Olczak S
Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
[TBL] [Abstract][Full Text] [Related]
17. COX-2-specific inhibitors and the kidney: effect on hypertension and oedema.
Whelton A
J Hypertens Suppl; 2002 Sep; 20(6):S31-5. PubMed ID: 12683425
[TBL] [Abstract][Full Text] [Related]
18. Renal effects of nonselective NSAIDs and coxibs.
Weir MR
Cleve Clin J Med; 2002; 69 Suppl 1():SI53-8. PubMed ID: 12086295
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
20. Renal effects of COX-2-selective inhibitors.
Brater DC; Harris C; Redfern JS; Gertz BJ
Am J Nephrol; 2001; 21(1):1-15. PubMed ID: 11275626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
